Home/Filings/4/0001209191-21-052088
4//SEC Filing

Chan M.P. Eric 4

Accession 0001209191-21-052088

CIK 0001433714other

Filed

Aug 16, 8:00 PM ET

Accepted

Aug 17, 8:04 PM ET

Size

25.5 KB

Accession

0001209191-21-052088

Insider Transaction Report

Form 4
Period: 2021-08-16
Chan M.P. Eric
Chief Accounting Officer
Transactions
  • Exercise/Conversion

    Restricted Stock Units (RSU)

    2021-08-166,25062,500 total
    Class B Common Stock (6,250 underlying)
  • Exercise/Conversion

    Class B Common Stock

    2021-08-16+4,687104,862 total
  • Exercise/Conversion

    Class B Common Stock

    2021-08-16+1,875108,300 total
  • Exercise/Conversion

    Class B Common Stock

    2021-08-16+6,250114,550 total
  • Exercise/Conversion

    Class B Common Stock

    2021-08-16+6,250120,800 total
  • Sale

    Class B Common Stock

    2021-08-17$1.71/sh7,739$13,210113,061 total
  • Exercise/Conversion

    Restricted Stock Units (RSU)

    2021-08-164,6874,688 total
    Class B Common Stock (4,687 underlying)
  • Exercise/Conversion

    Restricted Stock Units (RSU)

    2021-08-161,87511,250 total
    Class B Common Stock (1,875 underlying)
  • Exercise/Conversion

    Restricted Stock Units (RSU)

    2021-08-166,25087,500 total
    Class B Common Stock (6,250 underlying)
  • Exercise/Conversion

    Restricted Stock Units (RSU)

    2021-08-161,5633,118 total
    Class B Common Stock (1,563 underlying)
  • Exercise/Conversion

    Class B Common Stock

    2021-08-16+1,563106,425 total
Footnotes (8)
  • [F1]Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.
  • [F2]Represents the weighted average sales price per share. The shares sold at prices ranging from $1.6601 to $1.815 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  • [F3]Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration.
  • [F4]1/4th of the RSUs vested on November 16, 2018, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
  • [F5]1/16th of the RSUs vested on May 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
  • [F6]1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
  • [F7]1/16th of the RSUs vested on May 16, 2020, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
  • [F8]1/16th of the RSUs vested on May 16, 2021, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.

Issuer

CASTLIGHT HEALTH, INC.

CIK 0001433714

Entity typeother

Related Parties

1
  • filerCIK 0001717376

Filing Metadata

Form type
4
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 8:04 PM ET
Size
25.5 KB